Cargando…
4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition
4-phenylbutyrate (4-PBA), a terminal aromatic substituted fatty acid, is used widely to specifically attenuate endoplasmic reticulum (ER) stress and inhibit histone deacetylases (HDACs). In this study, we investigated the effect of 4-PBA on cardiac differentiation of mouse embryonic stem (ES) cells....
Autores principales: | Li, Yanming, Weng, Xiaofei, Wang, Pingping, He, Zezhao, Cheng, Siya, Wang, Dongxing, Li, Xianhui, Cheng, Guanchang, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059837/ https://www.ncbi.nlm.nih.gov/pubmed/33882103 http://dx.doi.org/10.1371/journal.pone.0250267 |
Ejemplares similares
-
The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats
por: Sandner, Guy, et al.
Publicado: (2011) -
Histone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition
por: Ma, Jing, et al.
Publicado: (2016) -
Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
por: Kusaczuk, Magdalena, et al.
Publicado: (2015) -
Inhibition of histone deacetylase (HDAC) by 4-phenylbutyrate results in increased junctional conductance between rat corpora smooth muscle cells
por: Wang, Hong Zhan, et al.
Publicado: (2015) -
Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination
por: Yadav, Anjali, et al.
Publicado: (2021)